APPLICATION
ANDA214831
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)
Products
BRIVARACETAMNone (Tentative Approval)
BRIVARACETAM 75mg · TABLET · ORAL
BRIVARACETAMNone (Tentative Approval)
BRIVARACETAM 25mg · TABLET · ORAL
BRIVARACETAMNone (Tentative Approval)
BRIVARACETAM 100mg · TABLET · ORAL
BRIVARACETAMNone (Tentative Approval)
BRIVARACETAM 50mg · TABLET · ORAL
Approval history
2024-05-24UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.